Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
AbbVie
(NY:
ABBV
)
193.62
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Sep 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about AbbVie
< Previous
1
2
3
4
5
6
7
8
9
...
67
68
Next >
10 Health Care Stocks Whale Activity In Today's Session
May 31, 2024
Via
Benzinga
2 Generic Drug Makers With Growing Runways
May 31, 2024
Brand name drug costs continue to climb but patients and insurers find respite by migrating to generic or biosimilar versions as patents run out.
Via
MarketBeat
Topics
Intellectual Property
Exposures
Intellectual Property
3 Dividend Stocks to Double Up on Right Now
May 30, 2024
The stories for these great dividend stocks are better than many might think.
Via
The Motley Fool
7 Biotech Stocks to Put on Your Breakthrough Radar
May 27, 2024
Although biotech stocks can present volatility risks due to its feast-or-famine nature, their narrative offers permanent relevance.
Via
InvestorPlace
Evolus: Chiseling Away At The Aesthetic Market
May 25, 2024
Via
Talk Markets
This Is What Whales Are Betting On AbbVie
May 22, 2024
Via
Benzinga
A Must-Own Stock for Any Portfolio
May 22, 2024
This company offers growth, high yield, and dividend growth.
Via
The Motley Fool
2 Billion More Reasons to Buy AbbVie Stock
May 22, 2024
This pharma giant just made a smart strategic acquisition.
Via
The Motley Fool
Forget Nvidia, Buy This Magnificent Healthcare Stock Instead
May 26, 2024
AbbVie's returns haven't been great this year, but investors shouldn't overlook this promising growth stock.
Via
The Motley Fool
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
May 25, 2024
These dividend stocks are ideal for investors seeking long-term passive income.
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
May 24, 2024
Via
Benzinga
After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information Stolen In Data Breach In February
May 24, 2024
Cencora reports a cyberattack exposing sensitive medical information, including patient names, addresses, birth dates, diagnoses, and medications.
Via
Benzinga
Topics
Data Breach
Exposures
Information Security
Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032
May 24, 2024
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:RENB),(NASDAQ:CYTO),(NYSE:PFE),(NYSE:ABBV) EQNX::TICKER_END
Via
FinancialNewsMedia
Topics
Death
Exposures
Death
Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032
May 24, 2024
From
FN Media Group LLC
Via
GlobeNewswire
3 Biotech Stocks to Buy on the Dip: May 2024
May 23, 2024
These biotech giants offer investors the best opportunity money can buy for excellent profits and returns this year.
Via
InvestorPlace
The Analyst Verdict: AbbVie In The Eyes Of 5 Experts
May 17, 2024
Via
Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,000 Today
May 16, 2024
Via
Benzinga
Unpacking the Latest Options Trading Trends in AbbVie
May 14, 2024
Via
Benzinga
8 Health Care Stocks Whale Activity In Today's Session
May 23, 2024
Via
Benzinga
The 100%+ Club: Piper Sandler’s 3 Top Picks for Triple-Digit Gains
May 22, 2024
Biotechs can see triple-digit returns or dramatic losses but these Piper Sandler stocks have the potential to achieve them.
Via
InvestorPlace
7 Safe-Haven Stocks to Weather Any Storm
May 22, 2024
Explore top safe-haven stocks to buy now for stability and consistent growth during economic turbulence and uncertainty.
Via
InvestorPlace
3 S&P 500 Stocks That Have Proven Themselves Recession-Proof
May 20, 2024
Corrections are a part of investing and investors would be smart to have these three S&P 500 stocks to buy when the inevitable happens.
Via
InvestorPlace
Topics
Stocks
Exposures
US Equities
1 Wall Street Analyst Thinks AbbVie Stock Is Going to $200. Is It a Buy at Around $165?
May 20, 2024
Revenue growth during what should be a disastrous patent cliff is encouraging.
Via
The Motley Fool
Topics
Intellectual Property
Exposures
Intellectual Property
Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch
May 18, 2024
President Joe Biden's administration is moving to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA).
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
10 Stocks to Build a Dividend Portfolio With
May 18, 2024
All 10 of these stocks pay reliable and growing dividends.
Via
The Motley Fool
AbbVie Is 'Successfully Positioned To Absorb Humira Biosimilar Erosion': Analyst
May 17, 2024
Cantor Fitzgerald initiates coverage on AbbVie with an Overweight rating and a $200 price target. AbbVie is set to manage Humira biosimilar erosion, drive growth with Skyrizi, Rinvoq, and emraclidine,...
Via
Benzinga
7 Value Stocks to Buy and Hold for a Decade of Dominance
May 17, 2024
Discover the enduring value of seven key value stocks to buy and hold in diverse sectors, presenting unparalleled opportunities.
Via
InvestorPlace
Wall Street Favorites: 3 Retirement Stocks With Strong Buy Ratings for May 2024
May 16, 2024
Amid the strong run in the market, investors thinking about long-term goals should consider these strongly endorsed retirement stocks to buy.
Via
InvestorPlace
Topics
Retirement
Exposures
Pension
Will Pharma And Healthcare Have Competitive Edge In Cannabis Post-Rescheduling? Data Analytics Expert Weighs In
May 14, 2024
Roy Bingham, CEO of BDSA, anticipates substantial growth in the U.S. cannabis market, projecting sales to reach nearly $46 billion by 2028.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
3 Magnificent Stocks That Are Passive Income Machines
May 14, 2024
These three companies have track records that should please investors.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
67
68
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.